Action WLLW WILLOW BIOSCIENCES INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Willow Biosciences Inc.

Actions

WLLW

CA97111B4047

Cours en clôture Toronto S.E.
Autres places de cotation
 00:00:00 26/06/2024 		Varia. 5j. Varia. 1 janv.
0,105 CAD -4,55% Graphique intraday de Willow Biosciences Inc. 0,00% +5,00%
26/06 Willow Biosciences fait le point sur ses activités et signe un nouveau programme en partenariat MT
30/05 Willow Biosciences Inc. annonce un partenariat de développement et de licence multiproduits avec Laurus Labs CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Willow Biosciences Provides Corporate Update and Signs New Partnered Program
Willow Biosciences Brief: Announced multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients
Willow Biosciences Brief: Expanding into the high growth biopesticide sector with addition of new partnered program
Willow Biosciences Brief: Announces its first patent being issued; Anticipates filing another five patents in 2024 primarily related to its steroid production platform
Willow Biosciences Brief: Anticipates revenue of over $1.0 million in Q2, and over $3.5 million for 2024 on existing programs
Willow Biosciences Brief: Providing Corporate Update and Signs New Partnered Program
WILLOW BIOSCIENCES PROVIDES CORPORATE UPDATE AND ANNOUNCES SIGNING OF A NEW PARTNERED PROGRAM
Willow Bioscience Announces 3 Million dollar Fundraising to Support Partnership with Laurus Labs
Willow Biosciences to Raise Up to $3 Million Via Brokered Private Placement; Shares Jumped 24% on Friday
Willow Biosciences Brief: Announcing Brokered Private Placement Offering To Raise Up To $3 Million
WILLOW ANNOUNCES BROKERED PRIVATE PLACEMENT OFFERING TO RAISE UP TO $3.0 MILLION
Willow Biosciences Inc. announced that it expects to receive CAD 3 million in funding
Willow Biosciences Signs Multi-Product Development, Licensing Partnership With Laurus Lab
Willow Biosciences Brief: Announcing Multi-product Development and Licensing Partnership With Laurus Lab
Willow Biosciences Inc. Announces Multi-Product Development and Licensing Partnership with Laurus Labs
WILLOW ANNOUNCES MULTI-PRODUCT DEVELOPMENT AND LICENSING PARTNERSHIP WITH LAURUS LABS FOR MANUFACTURING ACTIVE PHARMACEUTICAL INGREDIENTS
Willow Biosciences Brief: Reiterating its Expectations of at least doubling its full year 2024 revenues, As Reports Q1 Results
Willow Biosciences Inc. Provides Earnings Guidance for the Fiscal Year 2024
Willow Biosciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Willow Biosciences Narrows 2023 Loss YOY
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action WLLW
  4. Actualités Willow Biosciences Inc.
  5. Autres langues